Holen Sie sich die Stockscreener-App
111.39
3.19%
3.44
Handel nachbörslich:
111.40
0.01
+0.01%
Schlusskurs vom Vortag:
$107.95
Offen:
$109.4
24-Stunden-Volumen:
469.43K
Relative Volume:
1.70
Marktkapitalisierung:
$907.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.29%
1M Leistung:
+10.05%
6M Leistung:
+7.39%
1J Leistung:
+26.04%
1-Tages-Spanne:
$108.98
$111.72
1-Wochen-Bereich:
$106.79
$111.72
52-Wochen-Spanne:
$81.74
$112.58
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Firmenname
Vaneck Pharmaceutical Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare PPH vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
111.39 | 907.13M | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
368.76 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
744.78 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
748.43 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
300.34 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
712.60 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Aktie (PPH) Neueste Nachrichten
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.6248 - MSN
Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy? - AOL.com
Choosing Between VHT and PPH ETFs for Medical Sector Portfolios - HarianBasis.co
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - The Globe and Mail
Adding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns. - AOL.com
Should you invest in the VanEck pharmaceutical ETF (PPH)? - MSN
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
FHLC vs PPH: Choosing Between Broad Healthcare and Targeted Pharmaceuticals - sekbernews.id
PPH vs IXJ: Targeted Pharma ETF vs Broad Healthcare ETF — A Performance and Cost ComparisonDividend Growth Analysis - The Legal Advocate
PPH vs IXJ ETF Comparison: Pure Pharma vs Holistic Healthcare ExposureRevenue Growth Outlook - The Legal Advocate
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem - AOL.com
IHEiShares U.S. Pharmaceuticals ETF Stock Price and Quote - Finviz
PPH Stock Price, Quote & Chart | VANECK PHARMACEUTICAL ETF (NASDAQ:PPH) - ChartMill
Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery - Benzinga
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
VanEck Launches WARP ETF for Access to Rapidly Expanding Space Economy - MEXC
7 ETFs to Play a Healthcare Rebound - Barron's
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? - MSN
Introducing the VanEck Vectors Pharmaceutical ETF - Stock Investor
What's Going On With Merck Stock Tuesday? - Benzinga
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.8441 - MSN
VanEck Biotech ETF (BBH) stock price, news, quote and history - Yahoo Finance Singapore
VanEck Pharmaceutical ETF (PPHus) Stock Price Quote Today & Current Price Chart - Capital.com
VanEck ETF TrustVanEck Pharmaceutical ETF announces Quarterly dividend, payable on April 07, 2026 - MarketScreener
Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move - TradingView — Track All Markets
Pharma Stocks Pfizer, GSK Offer Defensive Plays in an Uncertain Market: Charts - Barron's
PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026 - AOL.com
VEFV ETF Analysis: Dividends, Returns MUN:VEFV - tradingview.com
VEFV ETF Holdings List — MUN:VEFV - TradingView
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs - TradingView
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
Finanzdaten der Vaneck Pharmaceutical Etf-Aktie (PPH)
Es liegen keine Finanzdaten für Vaneck Pharmaceutical Etf (PPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):